Correlation Between Biovaxys Technology and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Biovaxys Technology and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biovaxys Technology and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biovaxys Technology Corp and SAB Biotherapeutics, you can compare the effects of market volatilities on Biovaxys Technology and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biovaxys Technology with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biovaxys Technology and SAB Biotherapeutics.
Diversification Opportunities for Biovaxys Technology and SAB Biotherapeutics
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Biovaxys and SAB is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Biovaxys Technology Corp and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Biovaxys Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biovaxys Technology Corp are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Biovaxys Technology i.e., Biovaxys Technology and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Biovaxys Technology and SAB Biotherapeutics
Assuming the 90 days horizon Biovaxys Technology Corp is expected to generate 0.33 times more return on investment than SAB Biotherapeutics. However, Biovaxys Technology Corp is 3.03 times less risky than SAB Biotherapeutics. It trades about 0.04 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about -0.26 per unit of risk. If you would invest 4.14 in Biovaxys Technology Corp on November 27, 2024 and sell it today you would earn a total of 0.06 from holding Biovaxys Technology Corp or generate 1.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biovaxys Technology Corp vs. SAB Biotherapeutics
Performance |
| Timeline |
| Biovaxys Technology Corp |
| SAB Biotherapeutics |
Biovaxys Technology and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biovaxys Technology and SAB Biotherapeutics
The main advantage of trading using opposite Biovaxys Technology and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biovaxys Technology position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Biovaxys Technology vs. Biotron Limited | Biovaxys Technology vs. biOasis Technologies | Biovaxys Technology vs. Covalon Technologies | Biovaxys Technology vs. Mosaic Immunoengineering |
| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |